Have a personal or library account? Click to login
IgG Fc binding protein (FCGBP) inhibits the development of laryngeal squamous cell carcinoma and cisplatin resistance through the PIGR/JAK2/STAT3 pathway Cover

IgG Fc binding protein (FCGBP) inhibits the development of laryngeal squamous cell carcinoma and cisplatin resistance through the PIGR/JAK2/STAT3 pathway

Radiology and Oncology
Volume 60 (2026): Issue 1 (March 2026)
By: Xuemei Wan,  Yunlan Zeng,  Ming Xiong,  Lin Chen and  Yundan Bai  
Open Access
|Jan 2026

Authors

Xuemei Wan

Department of Otolaryngology Head and Neck Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, China
Department of Otolaryngology, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, China

Yunlan Zeng

Department of Otolaryngology, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, China

Ming Xiong

Department of Otolaryngology, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, China

Lin Chen

Department of Otolaryngology, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, China

Yundan Bai

byd1987@126.com

Department of Otolaryngology Head and Neck Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, China
Department of Otolaryngology, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, China
DOI: https://doi.org/10.2478/raon-2026-0003 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 67 - 75
Submitted on: Jun 20, 2025
|
Accepted on: Jul 25, 2025
|
Published on: Jan 21, 2026
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
laryngeal squamous cell carcinoma,
FCGBP,
PIGR/JAK2/STAT3,
cisplatin resistance
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2026 Xuemei Wan, Yunlan Zeng, Ming Xiong, Lin Chen, Yundan Bai, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 60 (2026): Issue 1 (March 2026)Next article